CLINICAL_TRIALS
trial_result
· 2017-12-04
Clinical Trial Update: Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant [Phase 3]
Summary
Phase 3 trial update on graft-versus-host disease prophylaxis in patients with hematologic malignancies undergoing unrelated donor peripheral blood stem cell tr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2017-12-04